Standard turnaround is counted in working days from receipt of your 50% advance and complete de-identified data. Express Priority delivery (+25%) is available on eligible services.
IEC-01
IEC-01
Complete ICMR-aligned synopsis and clinical study protocol including rationale, recent 5-year literature gap, primary/secondary objectives, inclusion/exclusion criteria, methodology workflow, and ethical risk-benefit justification.
Inspect Deliverable Structure
Sample Protocol Structure
1. Title & ICMR Risk Category | 2. Primary & Secondary Endpoints | 3. Study Design & Sample Size Justification | 4. Ethical Safeguards & DPDP Anonymization
IEC-02
IEC-02
Patient-friendly Participant Information Sheet (PIS) and Informed Consent Form (ICF) in English plus 1 Indian regional language (Telugu/Hindi), paired with a structured, de-identified Case Record Form (CRF).
Inspect Deliverable Structure
Sample Consent & CRF Checklist
Part A: Layperson Study Information & Voluntary Withdrawal | Part B: Signature & Witness Block | Part C: De-Identified Clinical Data Capture Sheet
IEC-03
IEC-03
Complete preparation of all 12 mandatory Clinical Trials Registry - India (CTRI) sections—including study design, PICO intervention/comparator definitions, outcome timepoints, and ethics attachment formatting.
Inspect Deliverable Structure
Sample CTRI Readiness Matrix
Trial Type & Phase: Observational / Interventional | Primary Outcome & Timepoint: Verified | IEC Approval & Consent Upload: Formatted
IEC-04
IEC-04
Comprehensive 10-SOP hospital pharmacy and clinical governance starter kit tailored for NABH accreditation—covering High-Alert Medications, LASA, Crash Carts, ADR Reporting, Antimicrobial Stewardship, Narcotics, Cold Chain, Ward Audits, Medication Errors, and Patient Data Privacy.
Inspect Deliverable Structure
Sample NABH SOP Header
SOP Code: PHM-SOP-01 (High-Alert Medications) | Purpose: Double-check protocol before dispensing & administration | Audit Metric: 100% compliance